NCT06828575

Brief Summary

The goal of this observational study is to evaluate the ability of artificial intelligence (AI) models to interpret arterial waveform analysis data obtained from a hemodynamic monitoring system in adult patients undergoing elective surgery. The main questions it aims to answer are: Can AI models (ChatGPT-4 and Gemini 2.0) accurately detect hemodynamic abnormalities in arterial waveform data? How well do AI-generated diagnoses align with expert anesthesiologist assessments? Are AI-generated treatment recommendations clinically appropriate? Participants will: Undergo standard hemodynamic monitoring with an arterial waveform analysis device (MostCare). Have their anonymized hemodynamic data analyzed by AI models for abnormality detection, diagnosis suggestions, and treatment recommendations. Have AI-generated results reviewed and validated by experienced anesthesiologists. This study aims to assess whether AI models can serve as decision-support tools in perioperative and critical care settings by improving the interpretation of complex hemodynamic data, potentially enhancing patient safety, diagnostic accuracy, and clinical efficiency.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
145

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 10, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 14, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

February 15, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 16, 2025

Completed
Last Updated

March 4, 2025

Status Verified

March 1, 2025

Enrollment Period

6 months

First QC Date

February 10, 2025

Last Update Submit

March 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Accuracy

    Accuracy of AI models in detecting hemodynamic abnormalities (True or False).

    1 day

Secondary Outcomes (2)

  • Concordance Between AI-Generated Diagnoses and Expert Anesthesiologist Diagnoses

    1 DAY

  • Clinical Appropriateness of AI-Generated Treatment Recommendations

    1 DAY

Interventions

predictions of learning language models

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

This study will include adult patients (≥18 years old) undergoing elective surgery requiring intraoperative arterial waveform monitoring as part of routine perioperative care. The population will consist of patients from two tertiary-level hospitals where advanced hemodynamic monitoring with the MostCare system is regularly utilized. Participants will be selected based on their eligibility for continuous arterial pressure monitoring, ensuring a standardized dataset for AI analysis. The study population will represent a diverse range of surgical procedures, including but not limited to: General surgery (e.g., abdominal, hepatobiliary, colorectal procedures)

You may qualify if:

  • Age ≥ 18 years
  • Undergoing elective surgery with arterial waveform monitoring as part of standard perioperative care
  • Hemodynamic data successfully recorded using the MostCare hemodynamic monitoring system
  • Able to provide informed consent to participate in the study

You may not qualify if:

  • Incomplete or corrupted hemodynamic data (e.g., signal artifacts preventing reliable analysis)
  • Emergency surgery cases
  • Patients with severe arrhythmias or hemodynamic instability that might interfere with arterial waveform interpretation
  • Refusal to participate or withdrawal of consent
  • Patients with contraindications to arterial catheterization (e.g., coagulopathy, severe peripheral vascular disease)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Health Science University İstanbul Kanuni Sultan Süleyman Education and Training Hospital

Istanbul, 34303, Turkey (Türkiye)

RECRUITING

MeSH Terms

Interventions

Drug Development

Intervention Hierarchy (Ancestors)

Investigative Techniques

Central Study Contacts

Engin ihsan Turan, Specialist

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
anesthesiology and reanimation specialist

Study Record Dates

First Submitted

February 10, 2025

First Posted

February 14, 2025

Study Start

February 15, 2025

Primary Completion

August 15, 2025

Study Completion

August 16, 2025

Last Updated

March 4, 2025

Record last verified: 2025-03

Locations